Celltrion
068270.KS
#771
Rank
S$34.60 B
Marketcap
$167.07
Share price
1.34%
Change (1 day)
-4.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of June 2024 : S$19.56 Billion

According to Celltrion 's latest financial reports the company's total assets are S$19.56 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31S$6.26 B-2.83%
2021-12-31S$6.44 B5.46%
2020-12-31S$6.11 B35.85%
2019-12-31S$4.49 B4.96%
2018-12-31S$4.28 B3.74%
2017-12-31S$4.13 B19.36%
2016-12-31S$3.46 B8.94%
2015-12-31S$3.17 B13.45%
2014-12-31S$2.80 B17.83%
2013-12-31S$2.37 B16.47%
2012-12-31S$2.04 B29.86%
2011-12-31S$1.57 B19.04%
2010-12-31S$1.32 B93.62%
2009-12-31S$0.68 B18.66%
2008-12-31S$0.57 B502.05%
2007-12-31S$95.47 M